WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Earnings & Revenue

INO past revenue growth

How has INO's revenue growth performed historically?
Company
-92.95%
Industry
83.05%
Market
15.22%
INO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INO earnings and revenue history

Current Revenue
$717.1k
Current Earnings
-$124.9M
Current Profit Margin
-17,423.4%

INO Return on Equity

Current Company
-96.2%
Current Industry
16.7%
Current Market
28.2%
INO's Return on Equity (-96.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when INO announces earnings.

INO Return on Assets

Current Company
-68.8%
Current Industry
3.2%
INO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INO Return on Capital Employed

Current Company
-117.16%
Current Industry
-43.6%
INO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INO$717.07k-$120.74M-$124.94M-53.15%N/A
ATNM$81.00k-$45.63M-$46.45M-95.46%N/A
ATAI$277.00k-$29.43M-$33.80M-99.53%N/A
XOMA$5.81M-$34.73M-$45.09M-14.83%N/A
INZY$0.00-$71.14M-$77.11MN/AN/A

Inovio Pharmaceuticals Earnings & Revenue FAQ

What were INO's earnings last quarter?

On Invalid Date, Inovio Pharmaceuticals (NASDAQ: INO) reported Q1 2024 earnings per share (EPS) of -$1.31, up 30.69% year over year. Total Inovio Pharmaceuticals earnings for the quarter were -$30.47 million. In the same quarter last year, Inovio Pharmaceuticals's earnings per share (EPS) was -$1.89.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.

What was INO's earnings growth in the past year?

As of Q2 2024, Inovio Pharmaceuticals's earnings has grown year over year. Inovio Pharmaceuticals's earnings in the past year totalled -$124.94 million.

What was INO's revenue last quarter?

On Invalid Date, Inovio Pharmaceuticals (NASDAQ: INO) reported Q1 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Inovio Pharmaceuticals's revenue was $114.94 thousand.

What was INO's revenue growth in the past year?

As of Q2 2024, Inovio Pharmaceuticals's revenue has grown -92.95% year over year. This is 176.01 percentage points lower than the US Biotechnology industry revenue growth rate of 83.05%. Inovio Pharmaceuticals's revenue in the past year totalled $717.07 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.